. . . . . . . . . "\"Y Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated cardiac failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product. Known hypersensitivity to product components. ( 4 Severe bradycardia. ( 4 Heart block greater than first degree. ( 4 Cardiogenic shock. ( 4 Decompensated cadiac failure. ( 4 Sick sinus syndrome without a pacemaker. ( 4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "NVBTqg/7zsXzsWc3MsyGl+4b0at3YJjBL5MtKP8C+/etGMd4n1I2uENMfMFwE7WyM0z18u0KQ9gFqlKrL4GhPWsJRzkFYElYsNuTX2TCDcvi2BHf14Hm7DPk9YIZ6h8yzyVgZbMSQpf6e4YkSrypwEd3wQHKmPr1RgG7PZjtZ54=" . . "2021-08-23T12:16:48.211+02:00"^^ . . . . .